The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

II.a

Pulmonary edema, noncardiogenic (NCPE)

Publications

Chang YJ, Min SK, Yoo JY, Kim JY

Acute pulmonary edema after local infiltration of epinephrine during mastoidectomy: A case report.

Korean journal of anesthesiology. 2009;56(4):462-465

Syal K, Ohri A, Thakur JR

Adrenaline induced pulmonary oedema.

Journal of anaesthesiology, clinical pharmacology. 2011;27(1):132-3

Pumphrey RS

Lessons for management of anaphylaxis from a study of fatal reactions.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2000;30(8):1144-50

Liu HP, Wu KC, Lu PP, Lin WT, Wang YL, Li AH, Wu RS, Tan PP

Delayed-onset epinephrine-induced pulmonary edema.

Anesthesiology. 1999;91(4):1169-70

Ersoz N, Finestone SC

Adrenaline-induced pulmonary oedema and its treatment. A report of two cases.

British journal of anaesthesia. 1971;43(7):709-12

Louise FR, Borghetti AF

New developments in synthetic bone replacement materials.

Current opinion in dentistry. 1992;2:97-103